Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane generation by human monocytes enhances platelet function.

D C Altieri, P M Mannucci

    The Journal of Experimental Medicine
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.

    Oncogene·2011
    Same author

    Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.

    British journal of cancer·2011
    Same author

    Caspase 2-mediated tumor suppression involves survivin gene silencing.

    Oncogene·2009
    Same author

    Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

    Oncogene·2009
    Same author

    Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.

    Oncogene·2009
    Same author

    New wirings in the survivin networks.

    Oncogene·2008

    Human monocytes enhance platelet aggregation and fibrinogen binding via thromboxane (Tx) synthesis. This rapid, transient effect, triggered by monocyte receptors, may disrupt normal hemostasis.

    Area of Science:

    • Immunology
    • Hematology
    • Cellular Biology

    Background:

    • Monocytes play a role in immune responses and inflammation.
    • Platelet aggregation is crucial for hemostasis and thrombosis.
    • The interaction between monocytes and platelets is not fully understood.

    Purpose of the Study:

    • To investigate the mechanism by which human monocytes enhance platelet aggregation.
    • To determine the role of thromboxane (Tx) in monocyte-mediated platelet potentiation.
    • To explore the implications of this interaction on hemostasis.

    Main Methods:

    • Monocyte-platelet co-incubation assays.
    • Measurement of 125I-fibrinogen binding to platelets.
    • Quantification of thromboxane (Tx) synthesis by monocytes.

    Related Experiment Videos

  • Assessment of platelet aggregation.
  • Identification of monocyte membrane receptors involved.

    • Main Results:

    • Human monocytes significantly potentiated ADP-stimulated platelet aggregation.
    • Monocyte-enhanced platelet function involved a fourfold increase in 125I-fibrinogen binding.
    • This potentiation was rapid, transient, and mediated by monocyte-synthesized thromboxane (Tx).
    • Tx generation was triggered by fibrinogen interaction with a specific monocyte membrane receptor.
    • Monocytes exhibit clot-promoting activity.

    Conclusions:

    • Human monocytes actively enhance platelet function through thromboxane (Tx) synthesis.
    • The interaction involves specific monocyte receptors and fibrinogen.
    • This monocyte-platelet interaction, alongside monocytes' clot-promoting activity, may lead to hemostatic imbalance.